nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrazinamide—AOX1—Methotrexate—psoriasis	0.187	0.242	CbGbCtD
Pyrazinamide—CYP1A2—Clobetasol propionate—psoriasis	0.174	0.225	CbGbCtD
Pyrazinamide—CYP1A2—Methoxsalen—psoriasis	0.0914	0.118	CbGbCtD
Pyrazinamide—CYP3A4—Calcitriol—psoriasis	0.0616	0.0795	CbGbCtD
Pyrazinamide—CYP3A4—Methoxsalen—psoriasis	0.0479	0.0619	CbGbCtD
Pyrazinamide—CYP3A4—Cholecalciferol—psoriasis	0.0317	0.041	CbGbCtD
Pyrazinamide—CYP3A4—Mycophenolate mofetil—psoriasis	0.0275	0.0355	CbGbCtD
Pyrazinamide—CYP3A4—Triamcinolone—psoriasis	0.0275	0.0355	CbGbCtD
Pyrazinamide—CYP3A4—Betamethasone—psoriasis	0.0236	0.0305	CbGbCtD
Pyrazinamide—CYP3A4—Prednisolone—psoriasis	0.0233	0.0301	CbGbCtD
Pyrazinamide—CYP3A4—Hydrocortisone—psoriasis	0.0221	0.0285	CbGbCtD
Pyrazinamide—CYP3A4—Prednisone—psoriasis	0.022	0.0284	CbGbCtD
Pyrazinamide—CYP3A4—Cyclosporine—psoriasis	0.0208	0.0269	CbGbCtD
Pyrazinamide—CYP3A4—Dexamethasone—psoriasis	0.0137	0.0177	CbGbCtD
Pyrazinamide—Myalgia—Acitretin—psoriasis	0.000847	0.00375	CcSEcCtD
Pyrazinamide—Arthralgia—Acitretin—psoriasis	0.000847	0.00375	CcSEcCtD
Pyrazinamide—Arthralgia—Fluocinolone Acetonide—psoriasis	0.000844	0.00374	CcSEcCtD
Pyrazinamide—Feeling abnormal—Methoxsalen—psoriasis	0.000843	0.00373	CcSEcCtD
Pyrazinamide—Discomfort—Acitretin—psoriasis	0.000837	0.0037	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Calcitriol—psoriasis	0.000831	0.00368	CcSEcCtD
Pyrazinamide—Rash—Beclomethasone—psoriasis	0.000825	0.00365	CcSEcCtD
Pyrazinamide—Dermatitis—Beclomethasone—psoriasis	0.000824	0.00365	CcSEcCtD
Pyrazinamide—Rash—Fluocinonide—psoriasis	0.000818	0.00362	CcSEcCtD
Pyrazinamide—Dermatitis—Fluocinonide—psoriasis	0.000817	0.00362	CcSEcCtD
Pyrazinamide—Urticaria—Methoxsalen—psoriasis	0.000813	0.0036	CcSEcCtD
Pyrazinamide—Body temperature increased—Methoxsalen—psoriasis	0.000809	0.00358	CcSEcCtD
Pyrazinamide—Decreased appetite—Calcitriol—psoriasis	0.000793	0.00351	CcSEcCtD
Pyrazinamide—Nausea—Beclomethasone—psoriasis	0.000777	0.00344	CcSEcCtD
Pyrazinamide—Anorexia—Acitretin—psoriasis	0.000774	0.00342	CcSEcCtD
Pyrazinamide—Hypersensitivity—Methoxsalen—psoriasis	0.000754	0.00334	CcSEcCtD
Pyrazinamide—Hepatitis—Mycophenolic acid—psoriasis	0.000751	0.00332	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Acitretin—psoriasis	0.000739	0.00327	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Fluocinolone Acetonide—psoriasis	0.000737	0.00326	CcSEcCtD
Pyrazinamide—Urticaria—Calcitriol—psoriasis	0.000725	0.00321	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Hydroxyurea—psoriasis	0.000724	0.00321	CcSEcCtD
Pyrazinamide—Pruritus—Methoxsalen—psoriasis	0.000724	0.00321	CcSEcCtD
Pyrazinamide—Body temperature increased—Calcitriol—psoriasis	0.000721	0.00319	CcSEcCtD
Pyrazinamide—Hyperuricaemia—Methotrexate—psoriasis	0.000721	0.00319	CcSEcCtD
Pyrazinamide—Dyspepsia—Acitretin—psoriasis	0.000714	0.00316	CcSEcCtD
Pyrazinamide—Dysuria—Cyclosporine—psoriasis	0.00071	0.00314	CcSEcCtD
Pyrazinamide—Decreased appetite—Acitretin—psoriasis	0.000706	0.00312	CcSEcCtD
Pyrazinamide—Malaise—Hydroxyurea—psoriasis	0.000704	0.00312	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Acitretin—psoriasis	0.000701	0.0031	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Fluocinolone Acetonide—psoriasis	0.000699	0.00309	CcSEcCtD
Pyrazinamide—Dysuria—Mycophenolate mofetil—psoriasis	0.000693	0.00307	CcSEcCtD
Pyrazinamide—Blood uric acid increased—Methotrexate—psoriasis	0.000681	0.00301	CcSEcCtD
Pyrazinamide—Hypersensitivity—Calcitriol—psoriasis	0.000672	0.00298	CcSEcCtD
Pyrazinamide—Feeling abnormal—Acitretin—psoriasis	0.000669	0.00296	CcSEcCtD
Pyrazinamide—Discomfort—Hydroxyurea—psoriasis	0.000657	0.00291	CcSEcCtD
Pyrazinamide—Pruritus—Calcitriol—psoriasis	0.000645	0.00286	CcSEcCtD
Pyrazinamide—Rash—Methoxsalen—psoriasis	0.000645	0.00286	CcSEcCtD
Pyrazinamide—Dermatitis—Methoxsalen—psoriasis	0.000645	0.00285	CcSEcCtD
Pyrazinamide—Urticaria—Acitretin—psoriasis	0.000645	0.00285	CcSEcCtD
Pyrazinamide—Body temperature increased—Acitretin—psoriasis	0.000642	0.00284	CcSEcCtD
Pyrazinamide—Body temperature increased—Fluocinolone Acetonide—psoriasis	0.00064	0.00283	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Hydroxyurea—psoriasis	0.000624	0.00276	CcSEcCtD
Pyrazinamide—Nausea—Methoxsalen—psoriasis	0.000608	0.00269	CcSEcCtD
Pyrazinamide—Hepatitis—Cyclosporine—psoriasis	0.000608	0.00269	CcSEcCtD
Pyrazinamide—Anorexia—Hydroxyurea—psoriasis	0.000607	0.00269	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Mycophenolic acid—psoriasis	0.000607	0.00269	CcSEcCtD
Pyrazinamide—Hypersensitivity—Acitretin—psoriasis	0.000598	0.00265	CcSEcCtD
Pyrazinamide—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.000596	0.00264	CcSEcCtD
Pyrazinamide—Hepatitis—Mycophenolate mofetil—psoriasis	0.000593	0.00262	CcSEcCtD
Pyrazinamide—Malaise—Mycophenolic acid—psoriasis	0.00059	0.00261	CcSEcCtD
Pyrazinamide—Vomiting—Calcitriol—psoriasis	0.00058	0.00257	CcSEcCtD
Pyrazinamide—Rash—Calcitriol—psoriasis	0.000575	0.00255	CcSEcCtD
Pyrazinamide—Dermatitis—Calcitriol—psoriasis	0.000575	0.00254	CcSEcCtD
Pyrazinamide—Pruritus—Acitretin—psoriasis	0.000574	0.00254	CcSEcCtD
Pyrazinamide—Pruritus—Fluocinolone Acetonide—psoriasis	0.000573	0.00253	CcSEcCtD
Pyrazinamide—Dyspepsia—Hydroxyurea—psoriasis	0.000561	0.00248	CcSEcCtD
Pyrazinamide—Myalgia—Mycophenolic acid—psoriasis	0.000557	0.00246	CcSEcCtD
Pyrazinamide—Arthralgia—Mycophenolic acid—psoriasis	0.000557	0.00246	CcSEcCtD
Pyrazinamide—Decreased appetite—Hydroxyurea—psoriasis	0.000554	0.00245	CcSEcCtD
Pyrazinamide—Photosensitivity—Methotrexate—psoriasis	0.000553	0.00245	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.00055	0.00243	CcSEcCtD
Pyrazinamide—Discomfort—Mycophenolic acid—psoriasis	0.00055	0.00243	CcSEcCtD
Pyrazinamide—Nausea—Calcitriol—psoriasis	0.000542	0.0024	CcSEcCtD
Pyrazinamide—Feeling abnormal—Hydroxyurea—psoriasis	0.000525	0.00232	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Mycophenolic acid—psoriasis	0.000523	0.00231	CcSEcCtD
Pyrazinamide—Vomiting—Acitretin—psoriasis	0.000516	0.00228	CcSEcCtD
Pyrazinamide—Vomiting—Fluocinolone Acetonide—psoriasis	0.000515	0.00228	CcSEcCtD
Pyrazinamide—Rash—Acitretin—psoriasis	0.000512	0.00227	CcSEcCtD
Pyrazinamide—Dermatitis—Acitretin—psoriasis	0.000511	0.00226	CcSEcCtD
Pyrazinamide—Rash—Fluocinolone Acetonide—psoriasis	0.00051	0.00226	CcSEcCtD
Pyrazinamide—Dermatitis—Fluocinolone Acetonide—psoriasis	0.00051	0.00226	CcSEcCtD
Pyrazinamide—Anorexia—Mycophenolic acid—psoriasis	0.000509	0.00225	CcSEcCtD
Pyrazinamide—Body temperature increased—Hydroxyurea—psoriasis	0.000504	0.00223	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Cyclosporine—psoriasis	0.000491	0.00217	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Mycophenolic acid—psoriasis	0.000486	0.00215	CcSEcCtD
Pyrazinamide—Nausea—Acitretin—psoriasis	0.000482	0.00213	CcSEcCtD
Pyrazinamide—Nausea—Fluocinolone Acetonide—psoriasis	0.000481	0.00213	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Mycophenolate mofetil—psoriasis	0.000479	0.00212	CcSEcCtD
Pyrazinamide—Malaise—Cyclosporine—psoriasis	0.000477	0.00211	CcSEcCtD
Pyrazinamide—Dyspepsia—Mycophenolic acid—psoriasis	0.00047	0.00208	CcSEcCtD
Pyrazinamide—Hypersensitivity—Hydroxyurea—psoriasis	0.000469	0.00208	CcSEcCtD
Pyrazinamide—Malaise—Mycophenolate mofetil—psoriasis	0.000465	0.00206	CcSEcCtD
Pyrazinamide—Decreased appetite—Mycophenolic acid—psoriasis	0.000464	0.00205	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000461	0.00204	CcSEcCtD
Pyrazinamide—Myalgia—Cyclosporine—psoriasis	0.00045	0.00199	CcSEcCtD
Pyrazinamide—Arthralgia—Cyclosporine—psoriasis	0.00045	0.00199	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Prednisolone—psoriasis	0.000447	0.00198	CcSEcCtD
Pyrazinamide—Discomfort—Cyclosporine—psoriasis	0.000445	0.00197	CcSEcCtD
Pyrazinamide—Feeling abnormal—Mycophenolic acid—psoriasis	0.00044	0.00195	CcSEcCtD
Pyrazinamide—Arthralgia—Mycophenolate mofetil—psoriasis	0.000439	0.00194	CcSEcCtD
Pyrazinamide—Myalgia—Mycophenolate mofetil—psoriasis	0.000439	0.00194	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Hydrocortisone—psoriasis	0.000436	0.00193	CcSEcCtD
Pyrazinamide—Malaise—Prednisolone—psoriasis	0.000434	0.00192	CcSEcCtD
Pyrazinamide—Discomfort—Mycophenolate mofetil—psoriasis	0.000434	0.00192	CcSEcCtD
Pyrazinamide—Malaise—Hydrocortisone—psoriasis	0.000424	0.00188	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Cyclosporine—psoriasis	0.000423	0.00187	CcSEcCtD
Pyrazinamide—Body temperature increased—Mycophenolic acid—psoriasis	0.000422	0.00187	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000412	0.00183	CcSEcCtD
Pyrazinamide—Anorexia—Cyclosporine—psoriasis	0.000412	0.00182	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Triamcinolone—psoriasis	0.000411	0.00182	CcSEcCtD
Pyrazinamide—Vomiting—Hydroxyurea—psoriasis	0.000405	0.00179	CcSEcCtD
Pyrazinamide—Discomfort—Prednisolone—psoriasis	0.000405	0.00179	CcSEcCtD
Pyrazinamide—Rash—Hydroxyurea—psoriasis	0.000402	0.00178	CcSEcCtD
Pyrazinamide—Anorexia—Mycophenolate mofetil—psoriasis	0.000401	0.00178	CcSEcCtD
Pyrazinamide—Dermatitis—Hydroxyurea—psoriasis	0.000401	0.00178	CcSEcCtD
Pyrazinamide—Myalgia—Hydrocortisone—psoriasis	0.0004	0.00177	CcSEcCtD
Pyrazinamide—Malaise—Triamcinolone—psoriasis	0.000399	0.00177	CcSEcCtD
Pyrazinamide—Discomfort—Hydrocortisone—psoriasis	0.000395	0.00175	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000393	0.00174	CcSEcCtD
Pyrazinamide—Dysuria—Methotrexate—psoriasis	0.000392	0.00174	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000384	0.0017	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Methotrexate—psoriasis	0.000383	0.0017	CcSEcCtD
Pyrazinamide—Dyspepsia—Cyclosporine—psoriasis	0.00038	0.00168	CcSEcCtD
Pyrazinamide—Nausea—Hydroxyurea—psoriasis	0.000378	0.00168	CcSEcCtD
Pyrazinamide—Pruritus—Mycophenolic acid—psoriasis	0.000378	0.00167	CcSEcCtD
Pyrazinamide—Myalgia—Triamcinolone—psoriasis	0.000377	0.00167	CcSEcCtD
Pyrazinamide—Decreased appetite—Cyclosporine—psoriasis	0.000375	0.00166	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000373	0.00165	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Dexamethasone—psoriasis	0.000373	0.00165	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Betamethasone—psoriasis	0.000373	0.00165	CcSEcCtD
Pyrazinamide—Discomfort—Triamcinolone—psoriasis	0.000372	0.00165	CcSEcCtD
Pyrazinamide—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000371	0.00164	CcSEcCtD
Pyrazinamide—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000366	0.00162	CcSEcCtD
Pyrazinamide—Anorexia—Hydrocortisone—psoriasis	0.000366	0.00162	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000364	0.00161	CcSEcCtD
Pyrazinamide—Malaise—Dexamethasone—psoriasis	0.000362	0.0016	CcSEcCtD
Pyrazinamide—Malaise—Betamethasone—psoriasis	0.000362	0.0016	CcSEcCtD
Pyrazinamide—Feeling abnormal—Cyclosporine—psoriasis	0.000356	0.00157	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.00035	0.00155	CcSEcCtD
Pyrazinamide—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000347	0.00154	CcSEcCtD
Pyrazinamide—Urticaria—Cyclosporine—psoriasis	0.000343	0.00152	CcSEcCtD
Pyrazinamide—Myalgia—Betamethasone—psoriasis	0.000342	0.00151	CcSEcCtD
Pyrazinamide—Myalgia—Dexamethasone—psoriasis	0.000342	0.00151	CcSEcCtD
Pyrazinamide—Body temperature increased—Cyclosporine—psoriasis	0.000341	0.00151	CcSEcCtD
Pyrazinamide—Vomiting—Mycophenolic acid—psoriasis	0.000339	0.0015	CcSEcCtD
Pyrazinamide—Discomfort—Dexamethasone—psoriasis	0.000338	0.0015	CcSEcCtD
Pyrazinamide—Discomfort—Betamethasone—psoriasis	0.000338	0.0015	CcSEcCtD
Pyrazinamide—Dyspepsia—Hydrocortisone—psoriasis	0.000338	0.00149	CcSEcCtD
Pyrazinamide—Rash—Mycophenolic acid—psoriasis	0.000336	0.00149	CcSEcCtD
Pyrazinamide—Dermatitis—Mycophenolic acid—psoriasis	0.000336	0.00149	CcSEcCtD
Pyrazinamide—Hepatitis—Methotrexate—psoriasis	0.000336	0.00149	CcSEcCtD
Pyrazinamide—Urticaria—Mycophenolate mofetil—psoriasis	0.000335	0.00148	CcSEcCtD
Pyrazinamide—Decreased appetite—Hydrocortisone—psoriasis	0.000334	0.00148	CcSEcCtD
Pyrazinamide—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000333	0.00147	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000331	0.00147	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000329	0.00146	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Prednisone—psoriasis	0.000325	0.00144	CcSEcCtD
Pyrazinamide—Feeling abnormal—Prednisolone—psoriasis	0.000324	0.00143	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Betamethasone—psoriasis	0.000321	0.00142	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Dexamethasone—psoriasis	0.000321	0.00142	CcSEcCtD
Pyrazinamide—Hypersensitivity—Cyclosporine—psoriasis	0.000318	0.00141	CcSEcCtD
Pyrazinamide—Dyspepsia—Triamcinolone—psoriasis	0.000318	0.00141	CcSEcCtD
Pyrazinamide—Nausea—Mycophenolic acid—psoriasis	0.000317	0.0014	CcSEcCtD
Pyrazinamide—Feeling abnormal—Hydrocortisone—psoriasis	0.000316	0.0014	CcSEcCtD
Pyrazinamide—Malaise—Prednisone—psoriasis	0.000315	0.0014	CcSEcCtD
Pyrazinamide—Anorexia—Betamethasone—psoriasis	0.000312	0.00138	CcSEcCtD
Pyrazinamide—Anorexia—Dexamethasone—psoriasis	0.000312	0.00138	CcSEcCtD
Pyrazinamide—Urticaria—Prednisolone—psoriasis	0.000312	0.00138	CcSEcCtD
Pyrazinamide—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.00031	0.00137	CcSEcCtD
Pyrazinamide—Pruritus—Cyclosporine—psoriasis	0.000305	0.00135	CcSEcCtD
Pyrazinamide—Urticaria—Hydrocortisone—psoriasis	0.000305	0.00135	CcSEcCtD
Pyrazinamide—Body temperature increased—Hydrocortisone—psoriasis	0.000303	0.00134	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000299	0.00132	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000299	0.00132	CcSEcCtD
Pyrazinamide—Pruritus—Mycophenolate mofetil—psoriasis	0.000298	0.00132	CcSEcCtD
Pyrazinamide—Arthralgia—Prednisone—psoriasis	0.000298	0.00132	CcSEcCtD
Pyrazinamide—Myalgia—Prednisone—psoriasis	0.000298	0.00132	CcSEcCtD
Pyrazinamide—Feeling abnormal—Triamcinolone—psoriasis	0.000298	0.00132	CcSEcCtD
Pyrazinamide—Discomfort—Prednisone—psoriasis	0.000294	0.0013	CcSEcCtD
Pyrazinamide—Hypersensitivity—Prednisolone—psoriasis	0.000289	0.00128	CcSEcCtD
Pyrazinamide—Dyspepsia—Dexamethasone—psoriasis	0.000289	0.00128	CcSEcCtD
Pyrazinamide—Dyspepsia—Betamethasone—psoriasis	0.000289	0.00128	CcSEcCtD
Pyrazinamide—Urticaria—Triamcinolone—psoriasis	0.000287	0.00127	CcSEcCtD
Pyrazinamide—Body temperature increased—Triamcinolone—psoriasis	0.000286	0.00126	CcSEcCtD
Pyrazinamide—Decreased appetite—Betamethasone—psoriasis	0.000285	0.00126	CcSEcCtD
Pyrazinamide—Decreased appetite—Dexamethasone—psoriasis	0.000285	0.00126	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000283	0.00125	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Betamethasone—psoriasis	0.000283	0.00125	CcSEcCtD
Pyrazinamide—Hypersensitivity—Hydrocortisone—psoriasis	0.000283	0.00125	CcSEcCtD
Pyrazinamide—Vomiting—Cyclosporine—psoriasis	0.000275	0.00122	CcSEcCtD
Pyrazinamide—Rash—Cyclosporine—psoriasis	0.000272	0.0012	CcSEcCtD
Pyrazinamide—Anorexia—Prednisone—psoriasis	0.000272	0.0012	CcSEcCtD
Pyrazinamide—Dermatitis—Cyclosporine—psoriasis	0.000272	0.0012	CcSEcCtD
Pyrazinamide—Pruritus—Hydrocortisone—psoriasis	0.000271	0.0012	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Methotrexate—psoriasis	0.000271	0.0012	CcSEcCtD
Pyrazinamide—Feeling abnormal—Dexamethasone—psoriasis	0.00027	0.0012	CcSEcCtD
Pyrazinamide—Feeling abnormal—Betamethasone—psoriasis	0.00027	0.0012	CcSEcCtD
Pyrazinamide—Vomiting—Mycophenolate mofetil—psoriasis	0.000268	0.00119	CcSEcCtD
Pyrazinamide—Hypersensitivity—Triamcinolone—psoriasis	0.000266	0.00118	CcSEcCtD
Pyrazinamide—Rash—Mycophenolate mofetil—psoriasis	0.000266	0.00118	CcSEcCtD
Pyrazinamide—Dermatitis—Mycophenolate mofetil—psoriasis	0.000265	0.00117	CcSEcCtD
Pyrazinamide—Malaise—Methotrexate—psoriasis	0.000264	0.00117	CcSEcCtD
Pyrazinamide—Urticaria—Betamethasone—psoriasis	0.00026	0.00115	CcSEcCtD
Pyrazinamide—Urticaria—Dexamethasone—psoriasis	0.00026	0.00115	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Prednisone—psoriasis	0.00026	0.00115	CcSEcCtD
Pyrazinamide—Body temperature increased—Betamethasone—psoriasis	0.000259	0.00115	CcSEcCtD
Pyrazinamide—Body temperature increased—Dexamethasone—psoriasis	0.000259	0.00115	CcSEcCtD
Pyrazinamide—Nausea—Cyclosporine—psoriasis	0.000256	0.00114	CcSEcCtD
Pyrazinamide—Pruritus—Triamcinolone—psoriasis	0.000256	0.00113	CcSEcCtD
Pyrazinamide—Dyspepsia—Prednisone—psoriasis	0.000251	0.00111	CcSEcCtD
Pyrazinamide—Nausea—Mycophenolate mofetil—psoriasis	0.00025	0.00111	CcSEcCtD
Pyrazinamide—Arthralgia—Methotrexate—psoriasis	0.000249	0.0011	CcSEcCtD
Pyrazinamide—Myalgia—Methotrexate—psoriasis	0.000249	0.0011	CcSEcCtD
Pyrazinamide—Decreased appetite—Prednisone—psoriasis	0.000248	0.0011	CcSEcCtD
Pyrazinamide—Rash—Prednisolone—psoriasis	0.000248	0.0011	CcSEcCtD
Pyrazinamide—Dermatitis—Prednisolone—psoriasis	0.000247	0.0011	CcSEcCtD
Pyrazinamide—Discomfort—Methotrexate—psoriasis	0.000246	0.00109	CcSEcCtD
Pyrazinamide—Vomiting—Hydrocortisone—psoriasis	0.000244	0.00108	CcSEcCtD
Pyrazinamide—Rash—Hydrocortisone—psoriasis	0.000242	0.00107	CcSEcCtD
Pyrazinamide—Dermatitis—Hydrocortisone—psoriasis	0.000242	0.00107	CcSEcCtD
Pyrazinamide—Feeling abnormal—Prednisone—psoriasis	0.000235	0.00104	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Methotrexate—psoriasis	0.000234	0.00103	CcSEcCtD
Pyrazinamide—Nausea—Prednisolone—psoriasis	0.000233	0.00103	CcSEcCtD
Pyrazinamide—Pruritus—Betamethasone—psoriasis	0.000232	0.00103	CcSEcCtD
Pyrazinamide—Pruritus—Dexamethasone—psoriasis	0.000232	0.00103	CcSEcCtD
Pyrazinamide—Vomiting—Triamcinolone—psoriasis	0.00023	0.00102	CcSEcCtD
Pyrazinamide—Nausea—Hydrocortisone—psoriasis	0.000228	0.00101	CcSEcCtD
Pyrazinamide—Rash—Triamcinolone—psoriasis	0.000228	0.00101	CcSEcCtD
Pyrazinamide—Dermatitis—Triamcinolone—psoriasis	0.000228	0.00101	CcSEcCtD
Pyrazinamide—Anorexia—Methotrexate—psoriasis	0.000227	0.00101	CcSEcCtD
Pyrazinamide—Urticaria—Prednisone—psoriasis	0.000227	0.001	CcSEcCtD
Pyrazinamide—Body temperature increased—Prednisone—psoriasis	0.000226	0.000999	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000217	0.000962	CcSEcCtD
Pyrazinamide—Nausea—Triamcinolone—psoriasis	0.000215	0.00095	CcSEcCtD
Pyrazinamide—Hypersensitivity—Prednisone—psoriasis	0.00021	0.000931	CcSEcCtD
Pyrazinamide—Dyspepsia—Methotrexate—psoriasis	0.00021	0.00093	CcSEcCtD
Pyrazinamide—Vomiting—Dexamethasone—psoriasis	0.000208	0.000923	CcSEcCtD
Pyrazinamide—Vomiting—Betamethasone—psoriasis	0.000208	0.000923	CcSEcCtD
Pyrazinamide—Decreased appetite—Methotrexate—psoriasis	0.000207	0.000918	CcSEcCtD
Pyrazinamide—Rash—Betamethasone—psoriasis	0.000207	0.000915	CcSEcCtD
Pyrazinamide—Rash—Dexamethasone—psoriasis	0.000207	0.000915	CcSEcCtD
Pyrazinamide—Dermatitis—Dexamethasone—psoriasis	0.000207	0.000914	CcSEcCtD
Pyrazinamide—Dermatitis—Betamethasone—psoriasis	0.000207	0.000914	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Methotrexate—psoriasis	0.000206	0.000912	CcSEcCtD
Pyrazinamide—Pruritus—Prednisone—psoriasis	0.000202	0.000894	CcSEcCtD
Pyrazinamide—Feeling abnormal—Methotrexate—psoriasis	0.000197	0.00087	CcSEcCtD
Pyrazinamide—Nausea—Dexamethasone—psoriasis	0.000195	0.000862	CcSEcCtD
Pyrazinamide—Nausea—Betamethasone—psoriasis	0.000195	0.000862	CcSEcCtD
Pyrazinamide—Urticaria—Methotrexate—psoriasis	0.00019	0.000839	CcSEcCtD
Pyrazinamide—Body temperature increased—Methotrexate—psoriasis	0.000189	0.000835	CcSEcCtD
Pyrazinamide—Vomiting—Prednisone—psoriasis	0.000182	0.000803	CcSEcCtD
Pyrazinamide—Rash—Prednisone—psoriasis	0.00018	0.000797	CcSEcCtD
Pyrazinamide—Dermatitis—Prednisone—psoriasis	0.00018	0.000796	CcSEcCtD
Pyrazinamide—Hypersensitivity—Methotrexate—psoriasis	0.000176	0.000778	CcSEcCtD
Pyrazinamide—Nausea—Prednisone—psoriasis	0.00017	0.000751	CcSEcCtD
Pyrazinamide—Pruritus—Methotrexate—psoriasis	0.000169	0.000747	CcSEcCtD
Pyrazinamide—Vomiting—Methotrexate—psoriasis	0.000152	0.000671	CcSEcCtD
Pyrazinamide—Rash—Methotrexate—psoriasis	0.00015	0.000666	CcSEcCtD
Pyrazinamide—Dermatitis—Methotrexate—psoriasis	0.00015	0.000665	CcSEcCtD
Pyrazinamide—Nausea—Methotrexate—psoriasis	0.000142	0.000627	CcSEcCtD
